BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Corrective action for Elecsys b-CrossLaps, Roche

Product group In-vitro diagnostics - immunological products
Reference 02400/13

Corrective action of Roche for Elecsys b-CrossLaps due to variation of sample stability and biotin inteference. Customers were informed accordingly.

Corrective action for Elecsys b-CrossLaps, Roche , Download_VeroeffentlichtAm_EN PDF, 98KB, File does not meet accessibility standards

Use of cookies

Cookies help us to provide our services. By using our website you agree that we can use cookies. Read more about our Privacy Policy and visit the following link: Privacy Policy (only in German)

OK